Highlights Acarix AB

Equities

ACARIX

SE0009268717

Market Closed - Nasdaq Stockholm Other stock markets 16:29:41 23/05/2024 BST			5-day change	1st Jan Change
0.313 ^SEK	-5.15%		+6.10%	+64.91%

05-14	Transcript : Acarix AB, Q1 2024 Earnings Call, May 14, 2024
05-14	Acarix AB Approves Board Elections	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Acarix AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Acarix Receives Order from the First Freestanding Emergency Room in the Us	04-29	CI
Acarix AB Announces Initiation of the First Us-Based Clinical Workflow Evaluation Study	04-11	CI
Acarix Announces the Results from 2024 American College of Cardiology Poster Presentation to Assess the Cost-Utility of the Cadscor System	04-08	CI
Acarix AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-15	CI
Acarix AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-15	CI
Acarix AB Advances the Utilization of Its CADScor System Within the Veterans Administration (Va) Healthcare Network	11-23	CI
Acarix AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
Acarix AB Expands Use of CADScor System into Osteopathic Medicine	27/09/23	CI
Acarix, Maeva Health to Launch Coronary Artery Disease Medical Device in Mauritius, East Africa	04/09/23	MT
Acarix AB Receives Initial Order from the Emerging East African Market	04/09/23	CI
Acarix AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	31/08/23	CI
First Veterans Affairs Healthcare System Standardizes Use of Acarix CADScor System	29/08/23	CI
Acarix AB Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23	CI
Acarix Announces the Release of A New Study Published in the March 2023 Issue of the Scientific Journal Heart	14/03/23	CI
Acarix Receives Breakthrough Order from US Veterans Health Administration	21/02/23	CI
Acarix AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	16/02/23	CI
Acarix AB Reports Earnings Results for the Full Year Ended December 31, 2022	16/02/23	CI
Acarix Secures Insurance Coverage in Texas and Receives First Cadscor®System Order	19/12/22	CI
Acarix Receives Additional Orders of CADScorÂ« System in Louisiana, USA	15/12/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Acarix AB

Equities

ACARIX

SE0009268717

Highlights

Filters